BROMFENAC SODIUM

BROMFENAC SODIUM was reported 1449 times

BROMFENAC SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IRIS BOMBE 1 0.0667
1 CONJUNCTIVAL RETRACTION 1 0.0625
2 LEUKAPHERESIS 1 0.0455
3 INSTILLATION SITE DISCOLOURATION 1 0.0417
4 GASTROINTESTINAL GANGRENE 1 0.0357
5 CORNEAL ENDOTHELIAL CELL LOSS 2 0.0294
6 ANTIBIOTIC ASSOCIATED COLITIS 1 0.0270
7 INSTILLATION SITE HAEMORRHAGE 1 0.0256
8 INSTILLATION SITE FOREIGN BODY SENSATION 3 0.0207
9 TOXIC ANTERIOR SEGMENT SYNDROME 22 0.0202
10 GIANT PAPILLARY CONJUNCTIVITIS 1 0.0200
11 AVIAN INFLUENZA 1 0.0156
12 ANTERIOR CHAMBER FIBRIN 2 0.0155
13 POSTERIOR CAPSULE OPACIFICATION 5 0.0146
14 HYPOPYON 12 0.0145
15 ARTHRITIS FUNGAL 1 0.0139
16 CRYOTHERAPY 1 0.0135
17 EYE INFECTION INTRAOCULAR 1 0.0128
18 CORNEAL INFILTRATES 4 0.0127
19 CORNEAL IRRITATION 1 0.0125
20 ANTERIOR CHAMBER CELL 8 0.0112
21 CORNEAL ABSCESS 1 0.0093
22 CORNEAL EROSION 5 0.0093
23 CORNEAL OEDEMA 20 0.0089
24 BILIRUBIN URINE PRESENT 1 0.0084
25 CHARLES BONNET SYNDROME 1 0.0083
26 PERIORBITAL PAIN 7 0.0083
27 INSTILLATION SITE LACRIMATION 2 0.0083
28 OCULAR PEMPHIGOID 1 0.0080
29 CORNEAL PERFORATION 5 0.0079
30 GLAUCOMA SURGERY 2 0.0078
31 INSTILLATION SITE DRYNESS 1 0.0078
32 CORNEAL DEFECT 1 0.0076
33 CYSTOID MACULAR OEDEMA 14 0.0074
34 CORNEAL OPACITY 10 0.0073
35 EYE ULCER 4 0.0069
36 CATARACT CORTICAL 1 0.0067
37 AORTIC VALVE THICKENING 1 0.0062
38 KERATITIS BACTERIAL 1 0.0061
39 INTRAOCULAR LENS IMPLANT 3 0.0061
40 ULCERATIVE KERATITIS 16 0.0058
41 OCULAR VASCULITIS 1 0.0058
42 INSTILLATION SITE SWELLING 1 0.0057
43 PANOPHTHALMITIS 1 0.0055
44 PUNCTATE KERATITIS 5 0.0054
45 FOREIGN BODY SENSATION IN EYES 34 0.0053
46 INSTILLATION SITE PAIN 13 0.0052
47 OCULAR PROCEDURAL COMPLICATION 1 0.0052
48 ANTERIOR CHAMBER INFLAMMATION 3 0.0050
49 POST PROCEDURAL INFLAMMATION 3 0.0048
50 LENS DISLOCATION 1 0.0048
51 CORNEAL GRAFT REJECTION 1 0.0048
52 ANTERIOR CHAMBER DISORDER 1 0.0043
53 ANTERIOR CHAMBER FLARE 1 0.0043
54 RETINAL OEDEMA 8 0.0042
55 EYELID PAIN 8 0.0039
56 GLARE 2 0.0039
57 HYPHAEMA 2 0.0038
58 INSTILLATION SITE DISCHARGE 1 0.0038
59 INTRAOCULAR PRESSURE DECREASED 2 0.0038
60 INSTILLATION SITE ERYTHEMA 2 0.0038
61 CONJUNCTIVITIS VIRAL 1 0.0038
62 DEPOSIT EYE 1 0.0037
63 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
64 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
65 SUPERFICIAL INJURY OF EYE 4 0.0037
66 CORNEAL ABRASION 5 0.0036
67 CHOROIDAL DETACHMENT 2 0.0036
68 VISUAL ACUITY TESTS ABNORMAL 2 0.0036
69 DERMAL ABSORPTION IMPAIRED 1 0.0036
70 BODY TINEA 2 0.0036
71 VITREOUS OPACITIES 3 0.0036
72 HALO VISION 4 0.0035
73 NON-INFECTIOUS ENDOPHTHALMITIS 3 0.0035
74 OESOPHAGEAL OEDEMA 1 0.0035
75 LENS DISORDER 1 0.0035
76 HYPOAESTHESIA EYE 2 0.0034
77 INSTILLATION SITE IRRITATION 4 0.0034
78 ENDOPHTHALMITIS 20 0.0033
79 CORNEA VERTICILLATA 1 0.0033
80 APOPTOSIS 1 0.0032
81 MEDICAL DEVICE SITE INFECTION 2 0.0032
82 BACTERIAL TRANSLOCATION 1 0.0032
83 CHALAZION 2 0.0031
84 CHORIORETINITIS 2 0.0031
85 CHONDROCALCINOSIS 2 0.0031
86 IODINE ALLERGY 1 0.0030
87 INTRAOCULAR PRESSURE TEST ABNORMAL 2 0.0028
88 DIALYSIS RELATED COMPLICATION 1 0.0028
89 CORNEAL DISORDER 6 0.0027
90 CATARACT OPERATION 16 0.0027
91 NEUROSARCOIDOSIS 1 0.0027
92 MULTIPLE DRUG THERAPY 2 0.0027
93 EYE ALLERGY 4 0.0026
94 PRODUCT KNOWLEDGE DEFICIT 2 0.0026
95 PRODUCT DROPPER ISSUE 2 0.0025
96 BRONCHITIS ACUTE 1 0.0025
97 REACTION TO PRESERVATIVES 2 0.0025
98 NORMAL PRESSURE HYDROCEPHALUS 1 0.0024
99 DYSCHROMATOPSIA 2 0.0024
100 CORNEAL DYSTROPHY 1 0.0024
101 SEROUS RETINAL DETACHMENT 2 0.0024
102 INTRAOCULAR PRESSURE INCREASED 30 0.0023
103 PRODUCT COLOUR ISSUE 12 0.0023
104 KERATITIS 7 0.0023
105 MOUTH BREATHING 1 0.0023
106 HIP DEFORMITY 1 0.0023
107 EYELID INFECTION 1 0.0023
108 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 2 0.0022
109 OCULAR DISCOMFORT 25 0.0022
110 HERNIA PAIN 1 0.0022
111 VITRITIS 4 0.0022
112 MACULAR OEDEMA 12 0.0021
113 ABNORMAL SENSATION IN EYE 9 0.0021
114 FOREIGN BODY IN EYE 2 0.0021
115 OCULAR HYPERTENSION 4 0.0021
116 DRAINAGE 1 0.0020
117 EYE PAIN 114 0.0020
118 BLEPHARITIS 8 0.0020
119 CORNEAL SCAR 1 0.0020
120 BLEPHARAL PIGMENTATION 1 0.0020
121 ASTIGMATISM 3 0.0020
122 IRITIS 6 0.0020
123 EYE COLOUR CHANGE 2 0.0020
124 EYE OPERATION 9 0.0020
125 IRIS ADHESIONS 1 0.0019
126 NASAL INFLAMMATION 2 0.0019
127 HYPERMETABOLISM 1 0.0019
128 CORYNEBACTERIUM INFECTION 1 0.0019
129 PHOTOPHOBIA 35 0.0019
130 IRIS DISORDER 1 0.0019
131 SUBRETINAL FLUID 2 0.0018
132 PRODUCT PHYSICAL CONSISTENCY ISSUE 10 0.0018
133 SLEEP TALKING 3 0.0018
134 CORNEAL EPITHELIUM DEFECT 1 0.0017
135 EYE BURNS 1 0.0017
136 EYE LASER SURGERY 1 0.0017
137 EYE IRRITATION 97 0.0017
138 EYE INFLAMMATION 16 0.0017
139 CYANOPSIA 1 0.0017
140 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
141 OPEN ANGLE GLAUCOMA 1 0.0016
142 JOINT WARMTH 2 0.0016
143 HEPATOBILIARY DISEASE 1 0.0016
144 HYPERPARATHYROIDISM SECONDARY 4 0.0016
145 SWELLING OF EYELID 10 0.0016
146 PERIORBITAL SWELLING 9 0.0016
147 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
148 AUTOIMMUNE COLITIS 1 0.0016
149 CONCOMITANT DISEASE PROGRESSION 3 0.0015
150 NEPHROGENIC ANAEMIA 7 0.0015
151 LIP EXFOLIATION 2 0.0015
152 INFUSION SITE RASH 2 0.0015
153 BRAIN CANCER METASTATIC 1 0.0014
154 DISCHARGE 2 0.0014
155 CATARACT 85 0.0014
156 CONJUNCTIVAL HYPERAEMIA 5 0.0014
157 CHYLOTHORAX 1 0.0014
158 DENTAL RESTORATION FAILURE 1 0.0014
159 NASAL INJURY 1 0.0014
160 DYSLALIA 1 0.0014
161 EYE DISCHARGE 14 0.0013
162 CORNEAL DEPOSITS 1 0.0013
163 AXILLARY PAIN 2 0.0013
164 ARTERIAL INJURY 1 0.0013
165 EXPOSURE TO COMMUNICABLE DISEASE 1 0.0013
166 CHROMATOPSIA 1 0.0013
167 AGE-RELATED MACULAR DEGENERATION 2 0.0013
168 PRODUCT DEPOSIT 2 0.0013
169 PRODUCT CONTAINER ISSUE 11 0.0013
170 CORNEAL TRANSPLANT 1 0.0013
171 KERATOPATHY 2 0.0013
172 INCORRECT DOSE ADMINISTERED BY PRODUCT 2 0.0012
173 VITREOUS FLOATERS 12 0.0012
174 RETINAL TEAR 3 0.0012
175 OCULAR VASCULAR DISORDER 1 0.0012
176 GIANT CELL ARTERITIS 1 0.0012
177 GASTROENTERITIS SALMONELLA 1 0.0012
178 OESOPHAGEAL RUPTURE 1 0.0012
179 EYELID IRRITATION 3 0.0012
180 DENTAL DISCOMFORT 1 0.0012
181 CHOROIDAL NEOVASCULARISATION 1 0.0012
182 ENDOCRINE OPHTHALMOPATHY 1 0.0012
183 CYSTOCELE 1 0.0012
184 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
185 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
186 PROTEIN TOTAL INCREASED 3 0.0011
187 RETINAL DETACHMENT 10 0.0011
188 METAMORPHOPSIA 2 0.0011
189 SMALL INTESTINAL PERFORATION 2 0.0011
190 HYPERMETROPIA 1 0.0011
191 RETINAL VEIN OCCLUSION 3 0.0010
192 VOCAL CORD DISORDER 2 0.0010
193 BRAIN STEM INFARCTION 1 0.0010
194 CONJUNCTIVAL OEDEMA 1 0.0010
195 CAROTID ARTERIOSCLEROSIS 1 0.0010
196 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
197 PRODUCT PRESCRIBING ERROR 23 0.0010
198 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
199 PHARYNGEAL ERYTHEMA 2 0.0009
200 JOINT CONTRACTURE 1 0.0009
201 INFUSION SITE BRUISING 2 0.0009
202 RENAL TUBULAR ACIDOSIS 2 0.0009
203 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
204 EYE INFECTION 10 0.0009
205 CARBON DIOXIDE DECREASED 1 0.0009
206 SINUS PAIN 2 0.0009
207 OCULAR HYPERAEMIA 40 0.0008
208 ORAL MUCOSA EROSION 1 0.0008
209 LACRIMATION INCREASED 24 0.0008
210 RETINAL ARTERY OCCLUSION 2 0.0008
211 MALLORY-WEISS SYNDROME 1 0.0008
212 ANGLE CLOSURE GLAUCOMA 2 0.0008
213 VISUAL ACUITY REDUCED 26 0.0008
214 BILIARY OBSTRUCTION 1 0.0008
215 RETINAL DISORDER 2 0.0008
216 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
217 VISION BLURRED 105 0.0008
218 PACKED RED BLOOD CELL TRANSFUSION 1 0.0008
219 OESOPHAGEAL HAEMORRHAGE 1 0.0008
220 MACULAR HOLE 1 0.0007
221 PRODUCT DELIVERY MECHANISM ISSUE 4 0.0007
222 SHOULDER ARTHROPLASTY 2 0.0007
223 SKIN WRINKLING 2 0.0007
224 ABSCESS ORAL 1 0.0007
225 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
226 THERAPEUTIC RESPONSE DELAYED 2 0.0007
227 GENITAL RASH 1 0.0007
228 DARK CIRCLES UNDER EYES 1 0.0007
229 GENERALISED ANXIETY DISORDER 1 0.0007
230 TOOTH DISCOLOURATION 2 0.0007
231 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
232 CONJUNCTIVITIS ALLERGIC 1 0.0007
233 GASTROINTESTINAL WALL THICKENING 1 0.0007
234 THROMBOPHLEBITIS SUPERFICIAL 2 0.0007
235 FOREIGN BODY IN THROAT 2 0.0006
236 NIGHT BLINDNESS 1 0.0006
237 GLAUCOMA 12 0.0006
238 PLASMA CELL MYELOMA RECURRENT 2 0.0006
239 INTESTINAL POLYP 1 0.0006
240 DRY EYE 30 0.0006
241 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
242 DIABETIC RETINOPATHY 2 0.0006
243 VARICOSE VEIN 3 0.0006
244 BLOOD CHLORIDE INCREASED 1 0.0006
245 ALOPECIA AREATA 1 0.0006
246 PANCREATIC FAILURE 1 0.0006
247 RETINAL HAEMORRHAGE 4 0.0006
248 AORTIC VALVE STENOSIS 1 0.0006
249 OPHTHALMIC HERPES ZOSTER 1 0.0006
250 VISUAL FIELD DEFECT 4 0.0006
251 EYE DISORDER 18 0.0005
252 ESSENTIAL HYPERTENSION 1 0.0005
253 ASTHENOPIA 3 0.0005
254 MYDRIASIS 7 0.0005
255 DEAFNESS UNILATERAL 3 0.0005
256 EYE SWELLING 20 0.0005
257 PARANASAL SINUS HYPERSECRETION 2 0.0005
258 ADRENAL DISORDER 1 0.0005
259 MOTION SICKNESS 1 0.0005
260 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
261 ABDOMINAL WALL HAEMATOMA 1 0.0005
262 EYE PRURITUS 17 0.0005
263 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0005
264 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
265 MICROCYTIC ANAEMIA 1 0.0005
266 PHOTOPSIA 3 0.0005
267 OPTIC NEUROPATHY 1 0.0005
268 MUSCLE FATIGUE 2 0.0005
269 LIPODYSTROPHY ACQUIRED 1 0.0005
270 ANAEMIA MACROCYTIC 1 0.0005
271 CATHETER SITE ERYTHEMA 1 0.0005
272 HORDEOLUM 2 0.0005
273 PRODUCT PRESCRIBING ISSUE 10 0.0005
274 TONGUE DISCOLOURATION 2 0.0005
275 IMMUNOSUPPRESSION 4 0.0005
276 BACTERIAL TEST POSITIVE 1 0.0004
277 PRODUCT USE COMPLAINT 7 0.0004
278 VISUAL IMPAIRMENT 55 0.0004
279 PRODUCT LABEL ISSUE 3 0.0004
280 BLOOD LOSS ANAEMIA 1 0.0004
281 HAEMATOCRIT INCREASED 1 0.0004
282 EAR DISORDER 2 0.0004
283 ORAL PRURITUS 1 0.0004
284 BREAKTHROUGH PAIN 1 0.0004
285 EXTRASYSTOLES 3 0.0004
286 BLINDNESS UNILATERAL 6 0.0004
287 CONTRAST MEDIA REACTION 1 0.0004
288 EXPIRED PRODUCT ADMINISTERED 14 0.0004
289 MYOPIA 1 0.0004
290 MEDICATION RESIDUE PRESENT 2 0.0004
291 LACUNAR INFARCTION 1 0.0004
292 LIMB OPERATION 2 0.0004
293 DRUG PRESCRIBING ERROR 8 0.0004
294 PAINFUL RESPIRATION 1 0.0004
295 HAEMATOLOGICAL INFECTION 1 0.0004
296 GLOMERULONEPHRITIS 1 0.0004
297 EYE OEDEMA 1 0.0004
298 DERMAL CYST 1 0.0004
299 TOOTH DISORDER 9 0.0004
300 LIGAMENT SPRAIN 4 0.0004
301 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
302 DEVICE INFUSION ISSUE 1 0.0004
303 ANEURYSM 2 0.0004
304 INFREQUENT BOWEL MOVEMENTS 1 0.0004
305 CHROMATURIA 9 0.0004
306 DERMATITIS ALLERGIC 5 0.0004
307 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
308 HAEMORRHAGE URINARY TRACT 1 0.0004
309 EAR DISCOMFORT 4 0.0004
310 MEAN CELL VOLUME INCREASED 1 0.0004
311 LIPOMA 1 0.0004
312 END STAGE RENAL DISEASE 7 0.0004
313 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
314 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
315 PRODUCT RESIDUE PRESENT 2 0.0004
316 RENAL INJURY 11 0.0004
317 HIP SURGERY 2 0.0004
318 ERYTHEMA OF EYELID 2 0.0004
319 UVEITIS 5 0.0004
320 CHRONIC KIDNEY DISEASE 28 0.0004
321 ORAL FUNGAL INFECTION 1 0.0004
322 NONSPECIFIC REACTION 2 0.0004
323 PRODUCT LEAKAGE 2 0.0004
324 SEASONAL ALLERGY 5 0.0004
325 IMPAIRED DRIVING ABILITY 4 0.0004
326 EYELID MARGIN CRUSTING 1 0.0003
327 ESCHERICHIA SEPSIS 1 0.0003
328 NECK INJURY 1 0.0003
329 HEPATITIS FULMINANT 1 0.0003
330 SINUS HEADACHE 2 0.0003
331 MACULAR DEGENERATION 4 0.0003
332 ATYPICAL PNEUMONIA 1 0.0003
333 DYSCHEZIA 1 0.0003
334 INCREASED TENDENCY TO BRUISE 3 0.0003
335 DRUG ADMINISTRATION ERROR 10 0.0003
336 EYELIDS PRURITUS 1 0.0003
337 BLEPHAROSPASM 2 0.0003
338 IRIDOCYCLITIS 1 0.0003
339 BLADDER PAIN 1 0.0003
340 BILE DUCT STONE 1 0.0003
341 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
342 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
343 LIVER ABSCESS 1 0.0003
344 BACTERIAL SEPSIS 1 0.0003
345 PHARYNGEAL SWELLING 3 0.0003
346 LYMPHOCYTE COUNT INCREASED 1 0.0003
347 HEPATOMEGALY 3 0.0003
348 SOMNAMBULISM 2 0.0003
349 DEAFNESS NEUROSENSORY 1 0.0003
350 PRODUCT FORMULATION ISSUE 2 0.0003
351 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
352 EYE HAEMORRHAGE 4 0.0003
353 MENINGITIS 2 0.0003
354 POSTOPERATIVE WOUND INFECTION 2 0.0003
355 EYELID PTOSIS 3 0.0003
356 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
357 CERVICAL VERTEBRAL FRACTURE 1 0.0003
358 BLOOD CREATININE ABNORMAL 1 0.0003
359 EMBOLIC STROKE 1 0.0003
360 BONE EROSION 1 0.0003
361 MACULOPATHY 1 0.0003
362 FIBRIN D DIMER INCREASED 1 0.0003
363 PULMONARY THROMBOSIS 3 0.0003
364 CAROTID ARTERY OCCLUSION 1 0.0003
365 FREEZING PHENOMENON 1 0.0003
366 CONJUNCTIVITIS 5 0.0003
367 REBOUND EFFECT 3 0.0003
368 PARANASAL SINUS DISCOMFORT 1 0.0003
369 PRODUCT AVAILABILITY ISSUE 6 0.0003
370 DERMATITIS CONTACT 3 0.0003
371 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
372 INSURANCE ISSUE 4 0.0003
373 GASTRIC INFECTION 1 0.0003
374 OESOPHAGEAL DISORDER 1 0.0003
375 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
376 EYELID OEDEMA 3 0.0003
377 MUSCLE RUPTURE 1 0.0003
378 NAIL DISCOLOURATION 1 0.0003
379 COVID-19 PNEUMONIA 3 0.0003
380 BACTERAEMIA 3 0.0003
381 ACCIDENT 3 0.0003
382 ENURESIS 1 0.0002
383 IMPAIRED HEALING 8 0.0002
384 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
385 THERAPY INTERRUPTED 17 0.0002
386 SENSATION OF FOREIGN BODY 2 0.0002
387 EATING DISORDER 5 0.0002
388 CARDIAC FAILURE CHRONIC 1 0.0002
389 ABSCESS LIMB 1 0.0002
390 INTERVERTEBRAL DISC DISORDER 1 0.0002
391 LUNG NEOPLASM 1 0.0002
392 ALCOHOLISM 1 0.0002
393 MUSCLE STRAIN 2 0.0002
394 DIPLOPIA 6 0.0002
395 URINE OUTPUT DECREASED 2 0.0002
396 DIVERTICULUM INTESTINAL 1 0.0002
397 MELANOCYTIC NAEVUS 1 0.0002
398 SPINAL OSTEOARTHRITIS 2 0.0002
399 PARONYCHIA 1 0.0002
400 PULMONARY CONGESTION 3 0.0002
401 HAEMORRHAGIC ANAEMIA 1 0.0002
402 GRIP STRENGTH DECREASED 2 0.0002
403 SARS-COV-2 TEST POSITIVE 3 0.0002
404 GINGIVAL SWELLING 1 0.0002
405 BLOOD CREATINE INCREASED 1 0.0002
406 WRONG DRUG ADMINISTERED 2 0.0002
407 FACIAL PAIN 2 0.0002
408 PAPILLOEDEMA 1 0.0002
409 DRUG EFFECT DELAYED 1 0.0002
410 TREATMENT NONCOMPLIANCE 12 0.0002
411 ABDOMINAL HERNIA 1 0.0002
412 DYSPAREUNIA 1 0.0002
413 TINNITUS 10 0.0002
414 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
415 NEPHROPATHY 2 0.0002
416 FLANK PAIN 2 0.0002
417 GASTRIC ULCER 4 0.0002
418 FEELING JITTERY 4 0.0002
419 SUBDURAL HAEMATOMA 3 0.0002
420 HERNIA 4 0.0002
421 PRODUCT USE IN UNAPPROVED INDICATION 51 0.0002
422 NEURALGIA 5 0.0002
423 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
424 HORMONE LEVEL ABNORMAL 1 0.0002
425 KIDNEY INFECTION 4 0.0002
426 THERAPY CHANGE 2 0.0002
427 KNEE OPERATION 2 0.0002
428 DISABILITY 4 0.0002
429 SINUS DISORDER 4 0.0002
430 INABILITY TO AFFORD MEDICATION 2 0.0002
431 APPLICATION SITE SWELLING 1 0.0002
432 BLOOD POTASSIUM DECREASED 6 0.0002
433 BRAIN INJURY 2 0.0002
434 FULL BLOOD COUNT DECREASED 4 0.0002
435 CORONARY ARTERIAL STENT INSERTION 1 0.0002
436 SLUGGISHNESS 2 0.0002
437 AMMONIA INCREASED 1 0.0002
438 FEMORAL NECK FRACTURE 1 0.0002
439 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
440 TENDERNESS 2 0.0002
441 MALABSORPTION 1 0.0002
442 WEIGHT FLUCTUATION 2 0.0002
443 FOOD CRAVING 1 0.0002
444 JOINT INJURY 4 0.0002
445 IMPAIRED WORK ABILITY 4 0.0002
446 BODY HEIGHT DECREASED 2 0.0002
447 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
448 COMPRESSION FRACTURE 1 0.0002
449 HIP FRACTURE 6 0.0002
450 LIVER FUNCTION TEST INCREASED 4 0.0002
451 SWELLING FACE 12 0.0002
452 BACK INJURY 2 0.0002
453 PRODUCT DOSE OMISSION 12 0.0002
454 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
455 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 33 0.0002
456 JAW DISORDER 1 0.0002
457 DENTAL CARIES 2 0.0002
458 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
459 CYTOMEGALOVIRUS INFECTION 3 0.0002
460 GASTRIC ULCER HAEMORRHAGE 1 0.0002
461 NERVE INJURY 2 0.0002
462 FISTULA 2 0.0002
463 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
464 INTENTIONAL DOSE OMISSION 5 0.0002
465 SCAR 3 0.0002
466 SKIN DISCOLOURATION 8 0.0002
467 MOUTH SWELLING 1 0.0002
468 ENTEROCOLITIS 1 0.0002
469 EXTRA DOSE ADMINISTERED 7 0.0002
470 DEVICE USE ISSUE 3 0.0002
471 BRADYKINESIA 1 0.0002
472 GALLBLADDER DISORDER 3 0.0002
473 GOUT 3 0.0002
474 WRIST FRACTURE 2 0.0002
475 TOOTHACHE 3 0.0002
476 HEPATITIS C 2 0.0002
477 ADRENAL INSUFFICIENCY 2 0.0002
478 CEREBRAL INFARCTION 4 0.0002
479 CARDIOMEGALY 2 0.0002
480 SMALL INTESTINAL OBSTRUCTION 2 0.0002
481 SPINAL OPERATION 2 0.0002
482 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
483 ILEUS 2 0.0002
484 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
485 PRODUCT USE ISSUE 30 0.0002
486 NASAL DRYNESS 1 0.0002
487 HOT FLUSH 12 0.0002
488 INFUSION SITE SWELLING 1 0.0002
489 MUSCLE ATROPHY 2 0.0002
490 BURNING SENSATION 11 0.0002
491 MOVEMENT DISORDER 5 0.0002
492 HYPERPROLACTINAEMIA 1 0.0002
493 APPLICATION SITE VESICLES 1 0.0002
494 DEAFNESS 4 0.0002
495 INCORRECT PRODUCT STORAGE 2 0.0002
496 TOOTH INFECTION 2 0.0002
497 HYPOKALAEMIA 7 0.0002
498 CORONAVIRUS INFECTION 1 0.0002
499 FUNGAL INFECTION 5 0.0001
500 HAIR TEXTURE ABNORMAL 2 0.0001
501 PRODUCT ADMINISTRATION ERROR 3 0.0001
502 COLITIS ISCHAEMIC 1 0.0001
503 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
504 PRODUCT QUALITY ISSUE 20 0.0001
505 BLINDNESS 6 0.0001
506 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
507 EYE MOVEMENT DISORDER 1 0.0001
508 ONYCHOCLASIS 1 0.0001
509 DROOLING 1 0.0001
510 HAIR GROWTH ABNORMAL 1 0.0001
511 DIVERTICULITIS 4 0.0001
512 LARGE INTESTINE PERFORATION 1 0.0001
513 ORAL DISCOMFORT 2 0.0001
514 BLOOD PRESSURE INCREASED 22 0.0001
515 HYPERTRANSAMINASAEMIA 1 0.0001
516 FORMICATION 1 0.0001
517 FEELING COLD 4 0.0001
518 RENAL FAILURE 19 0.0001
519 PRODUCT DOSE OMISSION ISSUE 42 0.0001
520 APPLICATION SITE REACTION 1 0.0001
521 HALLUCINATION, VISUAL 3 0.0001
522 PAPULE 1 0.0001
523 LYMPHOPENIA 2 0.0001
524 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
525 LYMPHADENOPATHY 5 0.0001
526 HAND FRACTURE 1 0.0001
527 RHINORRHOEA 9 0.0001
528 IMPAIRED QUALITY OF LIFE 2 0.0001
529 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
530 PRODUCT DISPENSING ERROR 3 0.0001
531 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
532 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
533 MAJOR DEPRESSION 1 0.0001
534 INFLAMMATION 7 0.0001
535 BLINDNESS TRANSIENT 1 0.0001
536 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
537 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
538 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
539 ARTHROPOD BITE 1 0.0001
540 DUODENAL ULCER PERFORATION 1 0.0001
541 PULMONARY MASS 2 0.0001
542 HYDRONEPHROSIS 1 0.0001
543 PAROSMIA 1 0.0001
544 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
545 HEPATOCELLULAR CARCINOMA 1 0.0001
546 DISCOMFORT 8 0.0001
547 FOOD ALLERGY 1 0.0001
548 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
549 TENDONITIS 2 0.0001
550 APHTHOUS ULCER 1 0.0001
551 PELVIC FRACTURE 1 0.0001
552 BASAL CELL CARCINOMA 2 0.0001
553 BRAIN FOG 2 0.0001
554 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
555 MULTIPLE ALLERGIES 1 0.0001
556 FURUNCLE 1 0.0001
557 PNEUMOTHORAX 2 0.0001
558 CYSTITIS 4 0.0001
559 SCIATICA 2 0.0001
560 BLOOD PRESSURE FLUCTUATION 3 0.0001
561 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
562 FRUSTRATION TOLERANCE DECREASED 1 0.0001
563 BLOOD POTASSIUM INCREASED 2 0.0001
564 DECUBITUS ULCER 1 0.0001
565 PRURITUS 47 0.0001
566 NO ADVERSE EVENT 22 0.0001
567 PHOTOSENSITIVITY REACTION 2 0.0001
568 OFF LABEL USE 106 0.0001
569 HEMIPLEGIA 1 0.0001
570 LIP SWELLING 4 0.0001
571 COAGULOPATHY 2 0.0001
572 HAEMODIALYSIS 1 0.0001
573 CANDIDA INFECTION 2 0.0001
574 PRODUCT COMPLAINT 3 0.0001
575 DIZZINESS 59 0.0001
576 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
577 RECTAL HAEMORRHAGE 5 0.0001
578 MUSCULOSKELETAL DISCOMFORT 2 0.0001
579 BLOOD MAGNESIUM DECREASED 1 0.0001
580 CARDIAC MURMUR 1 0.0001
581 STOMATITIS 7 0.0001
582 APPLICATION SITE ERYTHEMA 3 0.0001
583 GASTRITIS 3 0.0001
584 SLEEP DISORDER 8 0.0001
585 LYMPHOCYTE COUNT DECREASED 2 0.0001
586 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
587 CEREBRAL HAEMORRHAGE 4 0.0001
588 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
589 HAEMARTHROSIS 1 0.0001
590 MYOSITIS 1 0.0001
591 URINARY TRACT INFECTION 19 0.0001
592 FALL 37 0.0001
593 DRY MOUTH 9 0.0001
594 SYNOVITIS 2 0.0001
595 THROAT TIGHTNESS 3 0.0001
596 GASTROENTERITIS VIRAL 2 0.0001
597 OROPHARYNGEAL DISCOMFORT 1 0.0001
598 LIMB INJURY 3 0.0001
599 PALLOR 3 0.0001
600 RESTLESS LEGS SYNDROME 2 0.0001
601 BONE DISORDER 2 0.0001
602 EXOSTOSIS 1 0.0001
603 ACCIDENTAL OVERDOSE 4 0.0001
604 NASOPHARYNGITIS 20 0.0001
605 IRON DEFICIENCY ANAEMIA 1 0.0001
606 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
607 OROPHARYNGEAL PAIN 10 0.0001
608 MENTAL STATUS CHANGES 3 0.0001
609 ARTHROPATHY 6 0.0001
610 DEEP VEIN THROMBOSIS 7 0.0001
611 SINUSITIS 11 0.0001
612 RENAL DISORDER 5 0.0001
613 BACTERIAL INFECTION 2 0.0001
614 LACERATION 1 0.0001
615 ARTERIOSCLEROSIS 1 0.0001
616 FRACTURE 2 0.0001
617 ARRHYTHMIA 5 0.0001
618 COLITIS 4 0.0001
619 FOOT FRACTURE 2 0.0001
620 BLOOD URINE PRESENT 2 0.0001
621 NEUROPATHY PERIPHERAL 10 0.0001
622 DIABETES MELLITUS 8 0.0001
623 RED BLOOD CELL COUNT DECREASED 3 0.0001
624 PRODUCTIVE COUGH 5 0.0001
625 INCREASED APPETITE 2 0.0001
626 HERPES ZOSTER 6 0.0001
627 POST PROCEDURAL COMPLICATION 2 0.0001
628 SEIZURE 12 0.0001
629 COUGH 29 0.0001
630 EAR PAIN 2 0.0001
631 COVID-19 18 0.0001
632 SURGERY 6 0.0001
633 LABORATORY TEST ABNORMAL 3 0.0001
634 PSYCHOTIC DISORDER 3 0.0001
635 URINARY INCONTINENCE 3 0.0001
636 HAEMATOCRIT DECREASED 2 0.0001
637 BLADDER DISORDER 1 0.0001
638 BLOOD PRESSURE ABNORMAL 2 0.0001
639 PRESCRIBED UNDERDOSE 2 0.0001
640 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
641 TASTE DISORDER 2 0.0001
642 DRY THROAT 1 0.0001
643 DRUG LEVEL DECREASED 1 0.0001
644 MOTOR DYSFUNCTION 1 0.0001
645 NEUTROPHIL COUNT INCREASED 1 0.0001
646 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
647 SWOLLEN TONGUE 3 0.0001
648 DERMATITIS 2 0.0001
649 INCONTINENCE 1 0.0001
650 JOINT DISLOCATION 1 0.0001
651 BRONCHITIS 7 0.0001
652 HYPOTHYROIDISM 3 0.0001
653 IRRITABLE BOWEL SYNDROME 2 0.0001
654 HEREDITARY ANGIOEDEMA 1 0.0001
655 DECREASED ACTIVITY 1 0.0001
656 FAECES DISCOLOURED 2 0.0001
657 OEDEMA 5 0.0001
658 CONDITION AGGRAVATED 28 0.0001
659 BIPOLAR DISORDER 1 0.0001
660 GASTROINTESTINAL PAIN 1 0.0001
661 VIRAL INFECTION 3 0.0001
662 GAIT INABILITY 3 0.0001
663 WEIGHT DECREASED 25 0.0001
664 GLOSSODYNIA 2 0.0001
665 ORAL PAIN 2 0.0001
666 RASH PAPULAR 2 0.0001
667 SNEEZING 2 0.0001
668 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
669 BLISTER 5 0.0001
670 ARTHRITIS 7 0.0001
671 THERAPY NON-RESPONDER 4 0.0001
672 HEART RATE IRREGULAR 2 0.0001
673 ASTHENIA 33 0.0001
674 INTERNAL HAEMORRHAGE 1 0.0001
675 ILLNESS 9 0.0001
676 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
677 NEPHROLITHIASIS 4 0.0001
678 MUSCLE TWITCHING 2 0.0001
679 HAEMORRHAGE 9 0.0001
680 TREATMENT FAILURE 7 0.0001
681 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
682 BLOOD IRON DECREASED 1 0.0001
683 CHOLECYSTITIS 1 0.0001
684 HYPERLIPIDAEMIA 1 0.0001
685 LOCALISED INFECTION 2 0.0001
686 NOCTURIA 1 0.0001
687 ILL-DEFINED DISORDER 5 0.0001
688 PRESYNCOPE 2 0.0001
689 RESTLESSNESS 3 0.0001
690 CYTOPENIA 1 0.0001
691 DYSURIA 3 0.0001
692 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
693 HYPERCALCAEMIA 1 0.0001
694 DYSGEUSIA 6 0.0001
695 HEART RATE INCREASED 8 0.0001
696 INFLUENZA 9 0.0001
697 APPLICATION SITE IRRITATION 1 0.0001
698 INJECTION SITE DISCOLOURATION 1 0.0001
699 INTESTINAL OBSTRUCTION 3 0.0001
700 HAEMATEMESIS 2 0.0001
701 FLUSHING 8 0.0001
702 INJECTION SITE IRRITATION 1 0.0001
703 ACUTE KIDNEY INJURY 12 0.0001
704 GAIT DISTURBANCE 15 0.0001
705 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
706 CONSTIPATION 17 0.0001
707 INFUSION SITE PAIN 1 0.0001
708 SKIN ULCER 2 0.0001
709 HIATUS HERNIA 1 0.0001
710 HAEMATOMA 2 0.0001
711 EXPOSURE VIA SKIN CONTACT 2 0.0001
712 PLASMA CELL MYELOMA 3 0.0001
713 HEADACHE 48 0.0001
714 NERVOUSNESS 4 0.0001
715 HAND DEFORMITY 1 0.0001
716 ANHEDONIA 2 0.0001
717 BEDRIDDEN 1 0.0001
718 INFECTION 11 0.0001
719 DIARRHOEA 49 0.0001
720 IMMUNE SYSTEM DISORDER 1 0.0001
721 FATIGUE 59 0.0001
722 RASH 33 0.0001
723 ADVERSE REACTION 1 0.0001
724 EAR INFECTION 2 0.0001
725 CARDIAC DISORDER 7 0.0001
726 THROMBOSIS 6 0.0001
727 FEAR 2 0.0001
728 BLOOD BILIRUBIN INCREASED 2 0.0001
729 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
730 GINGIVAL BLEEDING 1 0.0001
731 CORONARY ARTERY OCCLUSION 1 0.0001
732 APPLICATION SITE RASH 1 0.0001
733 ABNORMAL DREAMS 2 0.0001
734 COORDINATION ABNORMAL 1 0.0001
735 APHONIA 1 0.0001
736 DEMENTIA 2 0.0001
737 MASS 1 0.0001
738 CARPAL TUNNEL SYNDROME 1 0.0001
739 PAIN IN EXTREMITY 21 0.0001
740 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
741 HYPERTENSION 15 0.0001
742 OSTEOARTHRITIS 3 0.0001
743 PAIN IN JAW 2 0.0001
744 MUSCULAR WEAKNESS 8 0.0001
745 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
746 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
747 HYPERHIDROSIS 9 0.0001
748 PARALYSIS 1 0.0001
749 ANGINA PECTORIS 2 0.0001
750 HYPERSOMNIA 2 0.0001
751 PRODUCT SUBSTITUTION ISSUE 4 0.0001
752 BALANCE DISORDER 6 0.0001
753 PARAESTHESIA ORAL 1 0.0001
754 HYPERTHYROIDISM 1 0.0001
755 SEPTIC SHOCK 3 0.0001
756 FLUID OVERLOAD 1 0.0001
757 NEEDLE ISSUE 2 0.0001
758 APATHY 1 0.0001
759 GASTROENTERITIS 1 0.0001
760 MUSCULOSKELETAL STIFFNESS 6 0.0001
761 CHEST DISCOMFORT 7 0.0001
762 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
763 NAUSEA 54 0.0001
764 ANAEMIA 13 0.0001
765 ANGIOEDEMA 3 0.0001
766 DEHYDRATION 9 0.0001
767 HAEMORRHAGE INTRACRANIAL 1 0.0001
768 EPISTAXIS 5 0.0001
769 HYPOAESTHESIA 10 0.0001
770 HALLUCINATION 5 0.0001
771 JOINT SWELLING 8 0.0001
772 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
773 ECONOMIC PROBLEM 1 0.0001
774 THERAPEUTIC RESPONSE DECREASED 4 0.0001
775 OSTEOPENIA 1 0.0001
776 PLATELET COUNT DECREASED 7 0.0001
777 URTICARIA 11 0.0001
778 DRUG DISPENSING ERROR 1 0.0001
779 HIP ARTHROPLASTY 1 0.0001
780 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
781 DEVICE RELATED INFECTION 1 0.0001
782 PERIPHERAL SWELLING 10 0.0001
783 LIMB DISCOMFORT 2 0.0001
784 ANKLE FRACTURE 1 0.0001
785 DECREASED APPETITE 15 0.0001
786 SOMNOLENCE 13 0.0001
787 DELUSION 1 0.0001
788 ERYTHEMA 13 0.0001
789 DYSPHAGIA 6 0.0001
790 HEAD INJURY 2 0.0001
791 PULMONARY EMBOLISM 6 0.0001
792 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
793 ABSCESS 1 0.0001
794 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
795 NIGHT SWEATS 2 0.0001
796 PNEUMONIA 20 0.0001
797 MUSCLE TIGHTNESS 1 0.0001
798 LUNG DISORDER 3 0.0001
799 ALOPECIA 12 0.0001
800 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
801 FEBRILE NEUTROPENIA 4 0.0001
802 BLOOD PRESSURE DECREASED 4 0.0001
803 SYNCOPE 6 0.0001
804 MUSCLE SPASMS 11 0.0001
805 NEOPLASM MALIGNANT 4 0.0001
806 PALPITATIONS 7 0.0001
807 BLOOD UREA INCREASED 1 0.0001
808 CHILLS 7 0.0001
809 CELLULITIS 3 0.0001
810 HYPERSENSITIVITY 11 0.0001
811 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
812 CEREBROVASCULAR ACCIDENT 10 0.0001
813 THERAPY CESSATION 3 0.0001
814 MEMORY IMPAIRMENT 8 0.0001
815 PYREXIA 20 0.0001
816 ORTHOSTATIC HYPOTENSION 1 0.0001
817 ECZEMA 3 0.0001
818 SPEECH DISORDER 3 0.0001
819 RASH MACULAR 2 0.0001
820 HEART RATE DECREASED 2 0.0001
821 HYPOXIA 2 0.0001
822 DYSPNOEA 32 0.0001
823 HEAD DISCOMFORT 1 0.0001
824 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
825 DRUG ERUPTION 1 0.0001
826 RASH PRURITIC 3 0.0001
827 OSTEOMYELITIS 1 0.0001
828 HYPOTENSION 11 0.0001
829 MALAISE 24 0.0001
830 LOSS OF CONSCIOUSNESS 7 0.0001
831 ANAPHYLACTIC REACTION 3 0.0001
832 TREMOR 9 0.0001
833 BLOOD GLUCOSE ABNORMAL 1 0.0001
834 HEPATIC STEATOSIS 1 0.0001
835 BREAST CANCER 5 0.0001
836 HEPATIC FUNCTION ABNORMAL 2 0.0001
837 OXYGEN SATURATION DECREASED 3 0.0001
838 HYPONATRAEMIA 3 0.0001
839 DYSPNOEA EXERTIONAL 2 0.0001
840 MYALGIA 9 0.0001
841 DEPRESSION 12 0.0001
842 MUSCULOSKELETAL DISORDER 1 0.0001
843 DRY SKIN 7 0.0001
844 MIGRAINE 5 0.0001
845 LETHARGY 3 0.0001
846 HOSPITALISATION 8 0.0001
847 ATRIAL FIBRILLATION 5 0.0001
848 DYSPHONIA 3 0.0001
849 HAEMORRHOIDS 1 0.0001
850 NASAL CONGESTION 3 0.0001
851 VOMITING 24 0.0001
852 DYSPEPSIA 5 0.0001
853 WHEEZING 3 0.0001
854 CYTOKINE RELEASE SYNDROME 1 0.0000
855 CARDIAC FAILURE CONGESTIVE 4 0.0000
856 BONE MARROW FAILURE 1 0.0000
857 FEELING HOT 3 0.0000
858 HAEMOGLOBIN DECREASED 5 0.0000
859 INJECTION SITE WARMTH 1 0.0000
860 ABDOMINAL PAIN UPPER 10 0.0000
861 DRUG DOSE OMISSION 8 0.0000
862 ABDOMINAL DISTENSION 5 0.0000
863 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
864 ROAD TRAFFIC ACCIDENT 2 0.0000
865 WITHDRAWAL SYNDROME 2 0.0000
866 MOUTH ULCERATION 1 0.0000
867 BACK PAIN 11 0.0000
868 HYPOACUSIS 2 0.0000
869 DEVICE DISLOCATION 2 0.0000
870 MENTAL DISORDER 2 0.0000
871 MYOCARDIAL INFARCTION 8 0.0000
872 PRODUCT STORAGE ERROR 4 0.0000
873 INTENTIONAL PRODUCT MISUSE 4 0.0000
874 APPLICATION SITE PAIN 1 0.0000
875 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
876 INSOMNIA 12 0.0000
877 DRUG INEFFECTIVE 59 0.0000
878 GASTROINTESTINAL DISORDER 4 0.0000
879 THROAT IRRITATION 2 0.0000
880 PANCREATITIS ACUTE 1 0.0000
881 APPLICATION SITE PRURITUS 1 0.0000
882 SKIN IRRITATION 2 0.0000
883 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
884 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
885 SWELLING 4 0.0000
886 BLOOD GLUCOSE INCREASED 8 0.0000
887 PAIN 26 0.0000
888 DISEASE PROGRESSION 5 0.0000
889 DISEASE RECURRENCE 2 0.0000
890 FEELING ABNORMAL 10 0.0000
891 BLOOD GLUCOSE DECREASED 2 0.0000
892 CONTUSION 4 0.0000
893 INTERSTITIAL LUNG DISEASE 2 0.0000
894 MENTAL IMPAIRMENT 1 0.0000
895 FIBROMYALGIA 1 0.0000
896 UNDERDOSE 3 0.0000
897 ARTHRALGIA 17 0.0000
898 LIVER INJURY 1 0.0000
899 AGEUSIA 1 0.0000
900 LEUKOPENIA 2 0.0000
901 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
902 ABDOMINAL PAIN LOWER 1 0.0000
903 FLUID RETENTION 2 0.0000
904 INJECTION SITE SWELLING 3 0.0000
905 HYPOPHAGIA 1 0.0000
906 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
907 ABDOMINAL PAIN 9 0.0000
908 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
909 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
910 JOINT STIFFNESS 1 0.0000
911 DERMATITIS ATOPIC 2 0.0000
912 BRADYCARDIA 2 0.0000
913 CONFUSIONAL STATE 6 0.0000
914 SEPSIS 4 0.0000
915 HAEMOPTYSIS 1 0.0000
916 THROMBOCYTOPENIA 4 0.0000
917 SKIN EXFOLIATION 3 0.0000
918 ASTHMA 4 0.0000
919 ANXIETY 10 0.0000
920 INCORRECT DOSE ADMINISTERED 8 0.0000
921 DYSSTASIA 1 0.0000
922 BONE PAIN 2 0.0000
923 ASCITES 1 0.0000
924 ACUTE MYOCARDIAL INFARCTION 1 0.0000
925 TACHYCARDIA 3 0.0000
926 DEVICE ISSUE 3 0.0000
927 ADVERSE DRUG REACTION 3 0.0000
928 CORONARY ARTERY DISEASE 1 0.0000
929 PLEURAL EFFUSION 2 0.0000
930 OEDEMA PERIPHERAL 4 0.0000
931 OVERDOSE 7 0.0000
932 CHEST PAIN 6 0.0000
933 FEMUR FRACTURE 1 0.0000
934 NERVOUS SYSTEM DISORDER 1 0.0000
935 PARAESTHESIA 5 0.0000
936 DRUG INTOLERANCE 3 0.0000
937 PSORIASIS 4 0.0000
938 OSTEONECROSIS 1 0.0000
939 INFUSION RELATED REACTION 2 0.0000
940 ANGER 1 0.0000
941 NEUTROPENIA 4 0.0000
942 GASTRIC DISORDER 1 0.0000
943 NIGHTMARE 1 0.0000
944 HYPERKALAEMIA 1 0.0000
945 INJURY 2 0.0000
946 SKIN BURNING SENSATION 2 0.0000
947 MOBILITY DECREASED 2 0.0000
948 DRUG EFFECT INCOMPLETE 1 0.0000
949 C-REACTIVE PROTEIN INCREASED 1 0.0000
950 HYPERGLYCAEMIA 1 0.0000
951 INJECTION SITE MASS 1 0.0000
952 DYSARTHRIA 1 0.0000
953 UNEVALUABLE EVENT 2 0.0000
954 INJECTION SITE HAEMORRHAGE 2 0.0000
955 EMOTIONAL DISTRESS 3 0.0000
956 NEUTROPHIL COUNT DECREASED 1 0.0000
957 LUNG NEOPLASM MALIGNANT 1 0.0000
958 INFLUENZA LIKE ILLNESS 2 0.0000
959 CARDIAC ARREST 2 0.0000
960 RENAL IMPAIRMENT 2 0.0000
961 WEIGHT INCREASED 5 0.0000
962 SUICIDAL IDEATION 2 0.0000
963 ADVERSE EVENT 2 0.0000
964 COGNITIVE DISORDER 1 0.0000
965 MULTIPLE SCLEROSIS 1 0.0000
966 DEATH 18 0.0000
967 HYPOGLYCAEMIA 1 0.0000
968 INJECTION SITE PAIN 6 0.0000
969 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
970 MUSCULOSKELETAL PAIN 1 0.0000
971 PANCREATITIS 1 0.0000
972 DISTURBANCE IN ATTENTION 1 0.0000
973 HAEMATOCHEZIA 1 0.0000
974 PANCYTOPENIA 1 0.0000
975 NECK PAIN 1 0.0000
976 ABDOMINAL DISCOMFORT 3 0.0000
977 TOXICITY TO VARIOUS AGENTS 3 0.0000
978 FLATULENCE 1 0.0000
979 INJECTION SITE ERYTHEMA 2 0.0000
980 BLOOD CREATININE INCREASED 1 0.0000
981 INJECTION SITE PRURITUS 1 0.0000
982 HEPATIC ENZYME INCREASED 1 0.0000
983 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
985 AGITATION 1 0.0000
986 DRUG INTERACTION 2 0.0000
987 INJECTION SITE BRUISING 1 0.0000
988 CARDIAC FAILURE 1 0.0000
989 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000